Cargando…

Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease

BACKGROUND: The Australian Imaging and Biomarker Lifestyle (AIBL) study of aging is designed to aid the discovery of biomarkers. The current study aimed to discover differentially expressed plasma proteins that could yield a blood-based screening tool for Alzheimer’s disease. METHODS: The concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Laffoon, Scott B., Doecke, James D., Roberts, Anne M., Vance, Jennifer A., Reeves, Benjamin D., Pertile, Kelly K., Rumble, Rebecca L., Fowler, Chris J., Trounson, Brett, Ames, David, Martins, Ralph, Bush, Ashley I., Masters, Colin L., Grieco, Paul A., Dratz, Edward A., Roberts, Blaine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790928/
https://www.ncbi.nlm.nih.gov/pubmed/35081972
http://dx.doi.org/10.1186/s12953-021-00185-9
_version_ 1784640121731022848
author Laffoon, Scott B.
Doecke, James D.
Roberts, Anne M.
Vance, Jennifer A.
Reeves, Benjamin D.
Pertile, Kelly K.
Rumble, Rebecca L.
Fowler, Chris J.
Trounson, Brett
Ames, David
Martins, Ralph
Bush, Ashley I.
Masters, Colin L.
Grieco, Paul A.
Dratz, Edward A.
Roberts, Blaine R.
author_facet Laffoon, Scott B.
Doecke, James D.
Roberts, Anne M.
Vance, Jennifer A.
Reeves, Benjamin D.
Pertile, Kelly K.
Rumble, Rebecca L.
Fowler, Chris J.
Trounson, Brett
Ames, David
Martins, Ralph
Bush, Ashley I.
Masters, Colin L.
Grieco, Paul A.
Dratz, Edward A.
Roberts, Blaine R.
author_sort Laffoon, Scott B.
collection PubMed
description BACKGROUND: The Australian Imaging and Biomarker Lifestyle (AIBL) study of aging is designed to aid the discovery of biomarkers. The current study aimed to discover differentially expressed plasma proteins that could yield a blood-based screening tool for Alzheimer’s disease. METHODS: The concentration of proteins in plasma covers a vast range of 12 orders of magnitude. Therefore, to search for medium to low abundant biomarkers and elucidate mechanisms of AD, we immuno-depleted the most abundant plasma proteins and pre-fractionated the remaining proteins by HPLC, prior to two-dimensional gel electrophoresis. The relative levels of approximately 3400 protein species resolved on the 2D gels were compared using in-gel differential analysis with spectrally resolved fluorescent protein detection dyes (Zdyes™). Here we report on analysis of pooled plasma samples from an initial screen of a sex-matched cohort of 72 probable AD patients and 72 healthy controls from the baseline time point of AIBL. RESULTS: We report significant changes in variants of apolipoprotein E, haptoglobin, α1 anti-trypsin, inter-α trypsin inhibitor, histidine-rich glycoprotein, and a protein of unknown identity. α1 anti-trypsin and α1 anti-chymotrypsin demonstrated plasma concentrations that were dependent on APOE ε4 allele dose. Our analysis also identified an association with the level of Vitamin D binding protein fragments and complement factor I with sex. We then conducted a preliminary validation study, on unique individual samples compared to the discovery cohort, using a targeted LC-MS/MS assay on a subset of discovered biomarkers. We found that targets that displayed a high degree of isoform specific changes in the 2D gels were not changed in the targeted MS assay which reports on the total level of the biomarker. CONCLUSIONS: This demonstrates that further development of mass spectrometry assays is needed to capture the isoform complexity that exists in theses biological samples. However, this study indicates that a peripheral protein signature has potential to aid in the characterization of AD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12953-021-00185-9.
format Online
Article
Text
id pubmed-8790928
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87909282022-01-26 Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease Laffoon, Scott B. Doecke, James D. Roberts, Anne M. Vance, Jennifer A. Reeves, Benjamin D. Pertile, Kelly K. Rumble, Rebecca L. Fowler, Chris J. Trounson, Brett Ames, David Martins, Ralph Bush, Ashley I. Masters, Colin L. Grieco, Paul A. Dratz, Edward A. Roberts, Blaine R. Proteome Sci Research BACKGROUND: The Australian Imaging and Biomarker Lifestyle (AIBL) study of aging is designed to aid the discovery of biomarkers. The current study aimed to discover differentially expressed plasma proteins that could yield a blood-based screening tool for Alzheimer’s disease. METHODS: The concentration of proteins in plasma covers a vast range of 12 orders of magnitude. Therefore, to search for medium to low abundant biomarkers and elucidate mechanisms of AD, we immuno-depleted the most abundant plasma proteins and pre-fractionated the remaining proteins by HPLC, prior to two-dimensional gel electrophoresis. The relative levels of approximately 3400 protein species resolved on the 2D gels were compared using in-gel differential analysis with spectrally resolved fluorescent protein detection dyes (Zdyes™). Here we report on analysis of pooled plasma samples from an initial screen of a sex-matched cohort of 72 probable AD patients and 72 healthy controls from the baseline time point of AIBL. RESULTS: We report significant changes in variants of apolipoprotein E, haptoglobin, α1 anti-trypsin, inter-α trypsin inhibitor, histidine-rich glycoprotein, and a protein of unknown identity. α1 anti-trypsin and α1 anti-chymotrypsin demonstrated plasma concentrations that were dependent on APOE ε4 allele dose. Our analysis also identified an association with the level of Vitamin D binding protein fragments and complement factor I with sex. We then conducted a preliminary validation study, on unique individual samples compared to the discovery cohort, using a targeted LC-MS/MS assay on a subset of discovered biomarkers. We found that targets that displayed a high degree of isoform specific changes in the 2D gels were not changed in the targeted MS assay which reports on the total level of the biomarker. CONCLUSIONS: This demonstrates that further development of mass spectrometry assays is needed to capture the isoform complexity that exists in theses biological samples. However, this study indicates that a peripheral protein signature has potential to aid in the characterization of AD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12953-021-00185-9. BioMed Central 2022-01-26 /pmc/articles/PMC8790928/ /pubmed/35081972 http://dx.doi.org/10.1186/s12953-021-00185-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Laffoon, Scott B.
Doecke, James D.
Roberts, Anne M.
Vance, Jennifer A.
Reeves, Benjamin D.
Pertile, Kelly K.
Rumble, Rebecca L.
Fowler, Chris J.
Trounson, Brett
Ames, David
Martins, Ralph
Bush, Ashley I.
Masters, Colin L.
Grieco, Paul A.
Dratz, Edward A.
Roberts, Blaine R.
Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
title Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
title_full Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
title_fullStr Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
title_full_unstemmed Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
title_short Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
title_sort analysis of plasma proteins using 2d gels and novel fluorescent probes: in search of blood based biomarkers for alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790928/
https://www.ncbi.nlm.nih.gov/pubmed/35081972
http://dx.doi.org/10.1186/s12953-021-00185-9
work_keys_str_mv AT laffoonscottb analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT doeckejamesd analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT robertsannem analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT vancejennifera analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT reevesbenjamind analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT pertilekellyk analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT rumblerebeccal analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT fowlerchrisj analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT trounsonbrett analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT amesdavid analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT martinsralph analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT bushashleyi analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT masterscolinl analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT griecopaula analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT dratzedwarda analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease
AT robertsblainer analysisofplasmaproteinsusing2dgelsandnovelfluorescentprobesinsearchofbloodbasedbiomarkersforalzheimersdisease